Dear Physio members:
I am going to receive a referral of a female who suffers facial
pain/headache status post face lift. If anyone has experience in
successfuly treating someone like her, please contact me. I will have more
specific information on her after her initial evaluation. She had 5
sessions of PT in another clinic and treatments included E-stim, US, etc...
She also had one nerve block. Sorry for the incomlete picture but I will
be greatly appreciated if you have any comment on this type of care.
Thank you in advance.
Sachiko Komagata, PT
[log in to unmask]
p.s. I attached an article I found through Medline search.
Date: 08-Apr-98
Name: T2596_21a000c_
Database: Medline <1995 to April 1998>
Set Search Results
---------------------------------------------------------------------------
001 surgical flaps/ae 143
002 (facial surgery and pain).ti,ab,sh. 3
003 from 2 keep 1 1
004 from 2 keep 1 1
005 from 2 keep 3 1
<1>
Unique Identifier
96015935
Authors
Lipp M. Daublander M. Sebastian M. Dick W.
Institution
Klinik fur Anasthesiologie, Johannes Gutenberg-Universitat Mainz.
Title
[Analgesia-sedation for maxillo-facial surgery with midazolam-pentazocine
and miazolam-ketamine. Clinical double-blind study of anxiety, analgesia,
sedation and amnesia]. [German]
Original Title
Analgosedierungsverfahren fur zahnarztlich-chirurgische Eingriffe mit
Midazolam/Pentazocin und Midazolam/Ketamin. Klinische Doppelblindstudie zu
Anxiolyse, Analgesie, Sedierung und Amnesie.
Source
Anaesthesist. 44(8):566-72, 1995 Aug.
MeSH Subject Headings
Adult
Ambulatory Surgical Procedures
Amnesia/ci [Chemically Induced]
Analgesia
*Anesthesia
*Anesthesia Adjuvants
*Anesthetics, Dissociative
Anxiety/pc [Prevention & Control]
Double-Blind Method
English Abstract
*Face/su [Surgery]
Human
Hypnotics and Sedatives
*Ketamine
*Maxilla/su [Surgery]
*Midazolam
*Pentazocine
Abstract
Ketamine and midazolam, applied as intravenous medication for conscious
sedation in day-case maxillo-facial surgery, has been proven to be
superior to pentazocine and midazolam concerning cardiovascular parameters
and respiratory depression. The aim of this study was to evaluate the
effects of low-dose ketamine/midazolam on anxiety, analgesia, amnesia and
subjective feelings. METHODS. 140 out-patients (ASA I) were randomly
divided into four groups. The double-blind study was prospective. Control
group: Local anaesthesia (LA), articaine 4% plus epinephrine 1:200,000 (n
= 35); test group P/M: LA, additional pentazocine 0.40 mg/kg bw and
midazolam 0.075 mg/kg bw i.v. (n = 35); test group K25/M: LA, additionally
ketamine 0.25 mg/kg bw and midazolam 0.075 mg/kg bw i.v. (n = 35), test
group K50/M: LA, additionally ketamine 0.5 mg/kg bw and midazolam 0.075
mg/kg bw i.v. (n = 35). LA was injected 3 min after application of the
systemic medication in the test groups or application of a placebo (saline
0.9%) in the control group. Three further minutes later, operation was
started. For evaluation questionnaires, visual analogue scales (VAS) and
the state-trait anxiety inventory (STAI) were used. For testing retrograde
and anterograde amnesia, acoustic sensations were delivered before
application of the systemic medication (a Christmas carol) and during
operation (the German national anthem). RESULTS. The control group and the
test groups were comparable with regard to biological data, duration of
operation, applied dosage of local anaesthetics and actual anxiety before
operation. The patients in all test groups rated intraoperative anxiety as
mild, in contrast to the control group. Nearly no pain sensation during
the operation was remembered in all test groups. Retrograde amnesia was
not found in any group. Complete anterograde amnesia was observed in all
test groups with respect to the intraoperative sensation, but even in the
control group 50% of the patients did not remember having heard the
national anthem. As subjective feelings negative criteria were mainly
reported in the control group, where as in all test groups positive
sensations dominated. Dreams were reported mostly after the higher dosage
of ketamine, but no patient experienced any unpleasant dreams. The
clinical assessment of the different regimes were excellent for test
groups P/M and K50/M, modest for the control group and test group K25/M.
Postoperatively, patients of test group P/M were remarkably sedated, but
no clinically relevant sedation or motor weakness were observed in the
other groups. Postoperative pain sensations were rated more intense in all
test groups than in the control group. In test groups P/M and K25/M an
increasing pain level was recorded during the postoperative period, with
the consequence of a higher demand rate for analgesics. CONCLUSIONS.
Dental surgery can be performed safely with low-dose ketamine/midazolam.
Compared to pentazocine/midazolam, the higher dosage of ketamine (0.5
mg/kg bw) showed identical results intraoperatively, but was superior
during the postoperative period (vigilance), and thus may represent a
suitable dosage. The lower dosage of ketamine resulted in worse operating
conditions, but a dosage higher than 0.5 mg/kg bw might lead to
unconscious sedation and might increase the frequency of unpleasant
dreams.
Registry Numbers
0 (Anesthesia Adjuvants). 0 (Anesthetics, Dissociative). 0 (Hypnotics
and Sedatives). 359-83-1 (Pentazocine). 59467-70-8 (Midazolam).
6740-88-1 (Ketamine).
|